48. Primary antiphospholipid syndrome
3 clinical trials,   4 drugs   (DrugBank: 3 drugs),   0 gene,   0 pathway

Searched query = "Primary antiphospholipid syndrome", "Primary antiphospholipid antibody syndrome", "Primary APS", "PAPS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03540810
(ClinicalTrials.gov)
August 15, 201827/4/2018Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid SyndromeHydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid SyndromePrimary Antiphospholipid SyndromeDrug: Hydroxychloroquine;Drug: PlaceboUniversity Hospital, AngersNULLNot yet recruiting18 YearsN/AAll300Phase 3France
2NCT04153201
(ClinicalTrials.gov)
January 15, 201321/10/2019Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid SyndromeEffect of Hydroxychloroquine on Thrombosis Prevention and Antiphospholipid Antibody Levels in Patients With Primary Antiphospholipid Syndrome: An Pilot Randomized Prospective Study.Antiphospholipid SyndromeDrug: HydroxychloroquineNational and Kapodistrian University of AthensNULLCompleted18 YearsN/AAll50N/AGreece